YOUR BUSINESS AUTHORITY
St. Louis biotech startup Arch Oncology raised $105 million in a funding round.
The round was led by Eventide Asset Management, Cowen Healthcare Investments and 3x5 Partners.
Arch Oncology is developing biologic therapies to treat patients with tumors and hematologic malignancies.
Read more from the St. Louis Business Journal.
In 50 years creating dioramas for museums, Terry Chase has become an authority mixing art and science.
Groundbreaking held for $9M housing development along Grant Avenue Parkway
MSU fundraising exec Dunn to stay on board
Nixa chamber president steps down
Construction to start this summer on $350M Lake of the Ozarks project
Software startup moving HQ to newly renovated building
Mexican restaurant plans April opening in former brewery